Bristol Myers Squibb to Participate in Raymond James Virtual 42nd Annual Institutional Investors Conference Biotech Investing
Bristol Myers Squibb and Celgene Issue Notices of Redemption and Partial Redemption of Certain of Their Senior Notes at "Make Whole" Prices Biotech Investing
Amgen Submits Supplemental New Drug Application for Otezla® for Adults with Mild-To-Moderate Plaque Psoriasis Biotech Investing
Second Phase 3 Induction Study Confirms Upadacitinib ) Improved Clinical, Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients Biotech Investing
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion Biotech Investing
AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation Biotech Investing
Bristol Myers Squibb Announces Early Participation Results and Early Settlement of Tender Offers for Up to an Aggregate Purchase Price of Up to $4.0 Billion Biotech Investing
